Arrowhead Pharmaceuticals Inc (ARWR)

Total asset turnover

		Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Revenue	US$ in thousands	222,409	243,231	138,287	87,992	168,796
Total assets	US$ in thousands	765,552	691,939	710,148	522,504	349,845
Total asset turnover		0.29	0.35	0.19	0.17	0.48

September 30, 2023 calculation

Total asset turnover = Revenue ÷ Total assets
= $222,409K ÷ $765,552K
= 0.29

The total asset turnover of Arrowhead Pharmaceuticals Inc. has fluctuated over the past five years, indicating varying levels of efficiency in generating sales from its total assets.

In 2023, the total asset turnover decreased to 0.31 from 0.35 in 2022, suggesting a decrease in its ability to generate sales from its total assets. This could be a sign of decreased efficiency in asset utilization or a larger asset base compared to the previous year.

In 2021, the total asset turnover increased to 0.19 from 0.17 in 2020, showing an improvement in the company's ability to generate sales from its total assets. However, the ratio remained relatively low compared to the other years, reflecting potential inefficiencies in asset utilization.

In 2019, the total asset turnover was at its highest at 0.48, indicating strong efficiency in generating sales from its total assets.

Overall, Arrowhead Pharmaceuticals Inc. has experienced fluctuations in its total asset turnover, highlighting the importance of closely monitoring its asset management and sales generation strategies.